Kidney patients offered new hope with a diabetes pill
NHS chiefs have granted roughly 91,000 sufferers access to the drug, dapagliflozin, which has slashed the risk of needing dialysis, a transplant and even death by up to 39 per cent.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Dapagliflozin | Diabetes | Dialysis | Endocrinology | Forxiga | Health | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology